FdaApplication
NDA 211280
Identifiers
- fda_app_no: NDA211280
Properties
| Property | Value |
|---|---|
| applicant_name | ELI LILLY AND CO |
| application_type | NDA |
| approval_date | 2020-01-31 |
Products (3)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| REYVOW | LASMIDITAN SUCCINATE | EQ 100MG BASE | TABLET;ORAL |
| REYVOW | LASMIDITAN SUCCINATE | EQ 50MG BASE | TABLET;ORAL |
| REYVOW | LASMIDITAN SUCCINATE | EQ 200MG BASE | TABLET;ORAL |
3 products